Analysis of Respiration-induced Deformities of the Visceral and Renal Arteries Before and After Stenting

Sponsor
Centre Chirurgical Marie Lannelongue (Other)
Overall Status
Completed
CT.gov ID
NCT04724863
Collaborator
(none)
15
1
1
8.8
1.7

Study Details

Study Description

Brief Summary

Fenestrated stents are used for the management of complex juxta-renal, para-renal or thoracoabdominal aneurysms in patients with high surgical risk and/or contraindicated for open surgery. These endovascular techniques have demonstrated their safety and efficacy, however, long-term follow-up CT scans remain essential for the detection of complications such as endo-leaks and restenosis/thrombosis of visceral and renal stents. The respiratory cycle might induce changes in the geometry and deformations of visceral and renal stents after complex aortic procedures. These could be detected by an adapted CT scan analysis by deep inhalation and deep exhalation acquisition carried out pre-operatively and post-operatively for monitoring of these same stents and screening for complications.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Angioscan
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Analysis of Respiration-induced Deformities of the Visceral and Renal Arteries Before and After Stenting for a Endovascular Aortic Repair Procedure Using a Fenestrated Prothesis
Actual Study Start Date :
Apr 28, 2020
Actual Primary Completion Date :
Oct 21, 2020
Actual Study Completion Date :
Jan 21, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Protocol

Each patient agreeing to participate in the study will be distributed in the protocol group and will receive an angioscan according to the protocol in pre-operative and at the usual post-operative check-up within 3 months after the operation. The usual procedure, foresees an angioscanner with injection of contrast product and the measurement of the images is performed during a deep breath. In order to obtain a complete respiratory cycle, the study procedure foresees in addition to the usual procedure, an image measurement during a deep exhalation.

Procedure: Angioscan
The study procedure foresees to take images during a deep breath as well as deep exhalation. This second measurement does not require the administration of an additional amount of contrast material. However, the exposure time to ionising radiation is doubled. The examination uses helical acquisition in fast mode. The duration of the helix is of the order of 2 seconds in the inspiration phase, then there is a delay of 5 seconds of machine time ("half-turn") and again 2 seconds of exposure in the expiration phase, i.e. 4 seconds of actual exposure to ionizing radiation, the time of image taking and 9 seconds the total time of the examination.

Outcome Measures

Primary Outcome Measures

  1. Geometry of the visceral and renal branches [1 day]

    An angioscanner will be performed with injection in inspiration and expiration (breathing cycle) before and after stent placement for a fenestrated aortic endografts. After reconstruction of a 3D volume of the aorta and extraction of the central lines of the different target arteries, the angle of the different visceral and renal branches will be measured during the respiratory cycle (inspiration; expiration) and compared before and after stenting.

Secondary Outcome Measures

  1. Endoleaks number [3 months]

  2. stenosis number [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • no contre indication for coroscanner
Exclusion Criteria:
  • pregnant woman

  • allergy to iodinated contrast media

  • vulnerable people

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hopital Marie Lannelongue Le Plessis-Robinson France 92350

Sponsors and Collaborators

  • Centre Chirurgical Marie Lannelongue

Investigators

  • Study Director: Stephan HAULON, Pr, Hopital Marie Lannelongue
  • Principal Investigator: Justine MOUGIN, Dr, Hopital Marie Lannelongue
  • Study Chair: Olaf MERCIER, Pr, Hopital Marie Lannelongue

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centre Chirurgical Marie Lannelongue
ClinicalTrials.gov Identifier:
NCT04724863
Other Study ID Numbers:
  • 2019-A02417-50
First Posted:
Jan 26, 2021
Last Update Posted:
Jan 26, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2021